FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and is intended for diagnostics of complications development in case of proliferative diabetic retinopathy in patients with non-transparent optic eye media. In lacrimal fluid of patients with proliferative diabetic retinopathy, determined are levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) obtained by ELISA method. If VEGF concentration is higher or equals 467 pg/ml and/or PEDF concentration is lower or equal 1.84 ng/ml, proliferative diabetic retinopathy with complications is diagnosed.
EFFECT: method allows to diagnose presence of proliferative diabetic retinopathy complications in patients with non-transparent optic eye media.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING INTRAOPERATIVE HEMORRHAGIC COMPLICATIONS IN HEAVY FORM OF DIABETIC RETHYNOPATHY | 2016 |
|
RU2626681C1 |
| METHOD FOR PREDICTION OF PROGRESSION OF DIABETIC RETINOPATHY AND DIABETIC MACULAR OEDEMA | 2013 |
|
RU2520826C1 |
| METHOD FOR PREDICTION OF DEVELOPING OR PROGRESSING PROLIFERATIVE SYNDROME IN ENDOGENOUS UVEITIS IN CHILDREN | 2015 |
|
RU2584246C1 |
| METHOD FOR PREDICTION OF EARLY PROGRESSING DIABETIC RETINOPATHY FOLLOWING ULTRASOUND PHACOEMULSIFICATION IN PATIENTS WITH DIABETES MELLITUS | 2011 |
|
RU2478961C1 |
| METHOD FOR EARLY DIAGNOSTICS AND PREDICTION OF DIABETIC AND HYPERTENSIVE RETINOPATHY PROGRESSING IN CASE OF COMBINED COURSE OF TYPE 2 DIABETES MELLITUS AND HYPERTENSIVE DISEASE | 2015 |
|
RU2610535C1 |
| METHOD FOR PREDICTION OF INTRAOPERATIVE HAEMORRHAGIC COMPLICATIONS IN THE SEVERE FORM OF PROLIFERATIVE DIABETIC RETINOPATHY | 2018 |
|
RU2696880C1 |
| METHOD FOR COMBINED SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY AND CATARACT | 2024 |
|
RU2826424C1 |
| METHOD FOR TREATMENT OF DIABETIC RETINOPATHY | 2021 |
|
RU2782996C1 |
| METHOD FOR PREDICTING HEMOPHTHALM DEVELOPMENT IN PATIENTS WITH DIABETES MELLITUS | 2001 |
|
RU2216744C2 |
| METHOD FOR TREATMENT OF CATARACT IN PATIENTS WITH ACTIVE NEOVASCULAR DISEASES OF MACULA | 2017 |
|
RU2659144C1 |
